Cytochrome P450 proteins influence drugs degradation in the body, but also trigger drug interactions. What influence do polymorphisms have on drug effects?
When Atum spread his divine seed over Egypt, could he have guessed that from the 18th century onwards masturbation would agitate the medical world so much?
Cancer mortality numbers increased during the COVID-19 pandemic, due to insufficient doctor–patient communication.
Doping and sports: the topic is always relevant when major international competitions, like the Olympic Games, are taking place.
An ongoing European study aims to assess the knowledge and perceptions of health professionals regarding medical cannabis.
"No one has impacted the very nature of medical marketing more than the multi-talented Dr. Arthur Sackler," says the Medical Advertising Hall of Fame about the man whose family name is now synonymous with the opioid epidemic.
Particle therapy fights with a prescribed high load and extreme precision against radioresistant tumors, while preserving healthy tissue.
2031. Catherine has a chronic illness. AI and digital interventions shape her care through diagnosis, psychological support, therapeutic guidance, and medication.
When physicians present to a colleague as a patient, should they disclose their profession? Are there subjective preferences, or an ethical duty to do so?
APAAACI´s recent white paper showed that various air pollutants threaten human respiratory and cardiovascular health
The APAAACI Task Force on COVID-19 recognized most common atopic conditions and skin allergies in healthcare workers during the pandemic.
Young physicians in Brazil and Ireland are struggling with anxiety disorder even months after working in clinical practice during the pandemic.
During pregnancy, women are not only at high risk for severe progression of the disease, they also face an increased risk of premature births and stillbirths.
In pathology, the protein Ki-67 is used to analyse conspicuous tissue changes. Researchers have discovered how this helpful protein is formed.
Compelling evidence suggests that many MS cases could be prevented by stopping EBV infection.
rFVIIIFc therapy realised immune tolerance in approximately 2 out of 3 patients with severe haemophilia A and high-titre inhibitors who underwent first ITI therapy.
The final trial results showed that younger and older patients with FLT3-ITD-mutated AML benefitted from adding midostaurin to intensive chemotherapy.
The large, population-based study showed prevalence in 40 years+ patients. Approximately 1 out of 3 smouldering MM patients may progress towards MM.
Fitusiran prophylactic therapy reduced the ABR in severe haemophilia A or B patients without inhibitors. Quality of life increase was associated with fitusiran therapy.
Teclistamab was safe and efficacious in relapsed/refractory multiple myeloma patients. Phase 1/2 trial showed durable and deepening responses.